A 12-centimeter calcified pancreatic mass that turned out to be surprisingly benign

A 31-year-old woman arrived at a hospital in Tunisia with progressive pain in her right upper abdomen. Imaging revealed a mass in the head of her pancreas measuring roughly 12.5 by 9 by 8 centimeters -- large enough to press against surrounding organs. CT and MRI showed a well-encapsulated, lobulated structure with solid, cystic, and unusually coarse calcified components. The tumor markers CEA and CA19-9 came back normal.

The combination of features -- size, location, calcification -- could suggest several diagnoses, some far more dangerous than others. She underwent a Whipple procedure (cephalic pancreaticoduodenectomy), and histopathology with immunohistochemistry confirmed the mass as a solid pseudopapillary neoplasm (SPN), a rare tumor accounting for under 3% of exocrine pancreatic cancers.

When calcification misleads

The case, published in Oncoscience by lead author Faten Limaiem of Hospital Mongi Slim La Marsa, is notable for what the calcification pattern did and did not indicate. Heavy calcification in a pancreatic mass can suggest aggressive or advanced disease. In this case, it did not. The microscopy revealed classic solid and pseudopapillary architecture with low mitotic activity -- features consistent with an indolent tumor.

SPN predominantly affects young women and generally carries an excellent prognosis after complete surgical resection. The authors emphasize that extensive calcification, while uncommon in SPN, should be recognized as part of the tumor's spectrum rather than interpreted as evidence of aggressive behavior. This matters because misidentifying the tumor type could lead to more aggressive treatment than necessary -- or, conversely, to delayed surgery if the calcification pattern confuses the diagnostic picture.

Surgical outcome and follow-up

Gross pathology of the resected mass showed cystic degeneration, hemorrhage, and the coarse calcifications visible on imaging. Immunohistochemistry confirmed nuclear beta-catenin and CD10 positivity, both markers consistent with SPN. The postoperative course was uneventful, and the patient remained recurrence-free at five months of follow-up.

Five months is a short follow-up window. The authors recommend at least five years of monitoring, noting that while SPN recurrence is rare, it does occur. Complete surgical resection remains the standard treatment and typically produces excellent outcomes even in cases with large, heavily calcified tumors.

A single case, a broader lesson

This is a case report -- a single patient. It does not establish new diagnostic criteria or treatment guidelines. Its value lies in documenting a presentation that could easily be mistaken for something more dangerous. The authors argue that integrating imaging, histopathology, and immunohistochemistry is essential for accurate diagnosis of pancreatic masses, particularly when calcification patterns do not fit neatly into established categories.

For clinicians encountering a large, calcified pancreatic mass in a young woman, SPN should remain on the differential, even when the calcification pattern suggests otherwise.